Target intelligence / Profile preview

5S ribosomal RNA pseudogene 292 (RNA5SP292)

Target
RNA5SP292
Molecular classification
Pseudogene, Non-coding RNA pseudogene, rRNA pseudogene
01

Overview

5S ribosomal RNA pseudogene 292 (RNA5SP292) is a genomic sequence homologous to the functional 5S ribosomal RNA gene, but with mutations, truncations, or other differences that prevent normal transcription or function[2][6]. This locus is classified as a non-coding RNA pseudogene and is part of the large family of ribosomal RNA pseudogenes found throughout the eukaryotic genome[2]. While the canonical 5S ribosomal RNA is essential for ribosome structure and protein synthesis[1][3][5], pseudogenes like RNA5SP292 lack these biological roles. Some pseudogenes have been hypothesized to play regulatory roles or act as competing endogenous RNAs in specific cancers[4], but the vast majority—including RNA5SP292—remain uncharacterized with respect to function, disease association, or therapeutic relevance. **Summary of key points:** - **RNA5SP292** is a non-functional pseudogene, not an active ribosomal RNA gene, receptor, enzyme, or therapeutic target[2][8]. - It is not known or validated as a drug target, biomarker, or participant in any defined disease or drug mechanism. - It should not be classified as a therapeutic target or receptor, and its presence in gene lists is usually a result of automated genome annotation pipelines, not functional characterization[2][6][8].

Other names
RN5S292RNA, 5S ribosomal 292RNA5SP292
02

Mechanism of action

none. No mechanism of drug action is associated with this pseudogene.

03

Biological functions

Other (may contribute to transcriptional noise or, rarely, regulatory functions, but lacks canonical ribosomal roles)
04

Disease associations

Other (many pseudogenes have been investigated for aberrant expression in cancer or as competing endogenous RNAs, but there is no evidence that RNA5SP292 is directly involved in specific disease processes)

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 292 (RNA5SP292).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 292 (RNA5SP292).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call